30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Alere Inc (ALR)

Track

Stock chart
Ticker: ALR Exchange: NYQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Guerdan Melissa
SVP, Global Quality & Reg.
1 sale — total 135,000 USD
Planned sale 1 Feb 2016
Value US$2,230,518.38 | Price 95.32 | Shares 32,487
Buy 13 Nov 2015
Value US$4,582,741.61 | Price 413.87 | Shares 47,147
Buy 12 Nov 2015
Value US$399,700.00 | Price 39.97 | Shares 10,000
Sale 3 Sep 2015
Value US$138,554.52 | Price 52.27 | Shares 2,651
Planned sale 1 Sep 2015
Value US$252,412.50 | Price 50.48 | Shares 5,000
Sale 31 Aug 2015
Value US$1,437,059.02 | Price 52.23 | Shares 27,513
Sale 14 Aug 2015
Value US$1,717,716.00 | Price 54.60 | Shares 31,460
Buy 7 Aug 2015
Value US$986,570.00 | Price 49.33 | Shares 20,000
Sale 8 Jun 2015
Value US$1,237,644.98 | Price 50.87 | Shares 24,331
Sale 4 Jun 2015
Value US$817,639.76 | Price 52.18 | Shares 15,669
Sale 1 Jun 2015
Value US$383,932.50 | Price 51.19 | Shares 7,500
Sale 29 May 2015
Value US$1,154,487.06 | Price 51.17 | Shares 22,564
Planned sale 30 Apr 2015
Value US$144,912.11 | Price 47.81 | Shares 3,031
Planned sale 6 Apr 2015
Value US$125,000.00 | Price 50.00 | Shares 2,500
Planned sale 23 Mar 2015
Value US$651,497.22 | Price 48.35 | Shares 13,476
Sale 17 Mar 2015
Value US$1,213,250.00 | Price 48.53 | Shares 25,000
Sale 16 Mar 2015
Value US$416,449.00 | Price 48.99 | Shares 8,500
Sale 23 Feb 2015
Value US$35,373.89 | Price 44.66 | Shares 792
Sale 23 Feb 2015
Value US$557,662.50 | Price 44.61 | Shares 12,500
Planned sale 16 Jan 2015
Value US$424,450.00 | Price 42.45 | Shares 10,000
Sale 13 Jan 2015
Value US$4,340.60 | Price 39.46 | Shares 110
Sale 11 Dec 2014
Value US$1,853,400.00 | Price 37.07 | Shares 50,000
Planned sale 15 Aug 2014
Value US$350,700.00 | Price 35.07 | Shares 10,000
Sale 11 Dec 2013
Value US$19,393.02 | Price 33.73 | Shares 575
Sale 11 Dec 2013
Value US$268,871.64 | Price 33.73 | Shares 7,972
Sale 13 Nov 2013
Value US$31,015.60 | Price 33.68 | Shares 921
Sale 12 Nov 2013
Value US$123,356.25 | Price 33.75 | Shares 3,655
Planned sale 15 Aug 2013
Value US$317,282.00 | Price 31.73 | Shares 10,000
Sale 5 Aug 2013
Value US$422,750.00 | Price 33.82 | Shares 12,500
Sale 31 May 2013
Value US$226,240.00 | Price 25.86 | Shares 8,750
Sale 7 Mar 2013
Value US$25,122.75 | Price 23.37 | Shares 1,075
Sale 5 Mar 2013
Value US$475,064.86 | Price 23.49 | Shares 20,220
Planned sale 1 Mar 2013
Value US$54,244.62 | Price 22.69 | Shares 2,391
Sale 14 Aug 2012
Value US$2,760.36 | Price 18.28 | Shares 151
Planned sale 7 Aug 2012
Value US$222,218.44 | Price 18.96 | Shares 11,721
Planned sale 19 Jul 2012
Value US$95,040.00 | Price 20.00 | Shares 4,752
Sale 13 Jun 2012
Value US$32,351.85 | Price 19.03 | Shares 1,700
Sale 13 Jun 2012
Value US$156,047.00 | Price 19.00 | Shares 8,213
Sale 13 Jun 2012
Value US$3,802.00 | Price 19.01 | Shares 200
Planned sale 7 Mar 2012
Value US$108,925.00 | Price 25.00 | Shares 4,357
Sale 16 Feb 2012
Value US$19,515.60 | Price 26.02 | Shares 750
Planned sale 7 Feb 2012
Value US$136,694.60 | Price 25.10 | Shares 5,446
Planned sale 2 Feb 2012
Value US$170,200.00 | Price 25.00 | Shares 6,808
Planned sale 28 Nov 2011
Value US$2,599,211.59 | Price 22.25 | Shares 116,829
Planned sale 15 Nov 2011
Value US$448,367.50 | Price 26.02 | Shares 17,229
Buy 23 Aug 2011
Value US$99,990.00 | Price 22.50 | Shares 4,444
Buy 11 Aug 2011
Value US$35,160.00 | Price 23.44 | Shares 1,500
Buy 9 Aug 2011
Value US$13,739.82 | Price 22.90 | Shares 600
Buy 9 Aug 2011
Value US$32,101.44 | Price 22.93 | Shares 1,400
Sale 15 Mar 2011
Value US$478,999.50 | Price 36.75 | Shares 13,034
Sale 15 Mar 2011
Value US$226,968.30 | Price 36.76 | Shares 6,175
Sale 12 Nov 2010
Value US$29,804.40 | Price 29.22 | Shares 1,020
Buy 27 Aug 2010
Value US$24,480.00 | Price 28.80 | Shares 850
Buy 30 Jul 2010
Value US$130,438.52 | Price 28.36 | Shares 4,600
Buy 30 Jul 2010
Value US$11,296.00 | Price 28.24 | Shares 400
Sale 17 May 2010
Value US$11,106.00 | Price 37.02 | Shares 300
Sale 17 May 2010
Value US$27,594.80 | Price 37.04 | Shares 745
Sale 17 May 2010
Value US$3,705.00 | Price 37.05 | Shares 100
Planned sale 26 Apr 2010
Value US$87,150.00 | Price 25.00 | Shares 3,486
Sale 19 Feb 2010
Value US$328,320.20 | Price 39.40 | Shares 8,333
Sale 16 Jun 2009
Value US$818,585.00 | Price 32.74 | Shares 25,000
Sale 16 Jun 2009
Value US$731,959.23 | Price 32.24 | Shares 22,700
Sale 26 Feb 2009
Value US$598,150.00 | Price 23.93 | Shares 25,000
Sale 1 Dec 2008
Value US$85,119.50 | Price 17.02 | Shares 5,000
Buy 24 Nov 2008
Value US$24,120.00 | Price 16.08 | Shares 1,500
Buy 24 Nov 2008
Value US$863,580.00 | Price 15.56 | Shares 55,500
Buy 24 Nov 2008
Value US$104,440.00 | Price 14.92 | Shares 7,000
Buy 21 Nov 2008
Value US$746,192.54 | Price 13.43 | Shares 55,555
Sale 21 Nov 2008
Value US$62,376.00 | Price 13.56 | Shares 4,600
Sale 21 Nov 2008
Value US$226,842.00 | Price 14.73 | Shares 15,400
Sale 20 Nov 2008
Value US$783,488.70 | Price 14.73 | Shares 53,190
Sale 20 Nov 2008
Value US$373,195.20 | Price 13.92 | Shares 26,810
Buy 5 Jun 2008
Value US$192,800.00 | Price 38.56 | Shares 5,000
Buy 2 Jun 2008
Value US$998,016.00 | Price 36.16 | Shares 27,600
Buy 5 Mar 2008
Value US$25,198.25 | Price 30.25 | Shares 833
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-02-03 2016-02-01 PlS Planned sale Guerdan Melissa

SVP, Global Quality & Reg.

Officer
32,487 +10.5%
95.32
US$2,230,518 		32,487 +10.5% 95.32 US$2,230,518
2015-11-16 2015-11-13 B Purchase Hargadon Robert Bernard

SVP, Global Human Resources

Officer
47,147 -33.3%
413.87
US$4,582,742 		47,147 -33.3% 413.87 US$4,582,742
2015-11-12 2015-11-12 B Purchase Hinrichs James F.

Executive VP, CFO

Officer
68,710 -19.3%
122.47
US$2,691,095 		68,710 -19.3% 122.47 US$2,691,095
2015-09-04 2015-09-03 S Sale Gladwell Mark

Senior VP, Global Operations

Officer
2,651 -100.0%
52.27
US$138,555 		2,651 -100.0% 52.27 US$138,555
2015-09-02 2015-09-01 PlS Planned sale Guerdan Melissa

SVP, Global Quality & Reg.

Officer
5,000 -49.3%
50.48
US$252,412 		5,000 -49.3% 50.48 US$252,412
2015-09-02 2015-08-31 S Sale Gladwell Mark

Senior VP, Global Operations

Officer
27,513 -91.2%
52.23
US$1,437,059 		27,513 -91.2% 52.23 US$1,437,059
2015-08-18 2015-08-14 S Sale Malkani Sanjay

Global Pres., Toxicology

Officer
31,460 -83.5%
54.60
US$1,717,716 		31,460 -83.5% 54.60 US$1,717,716
2015-08-10 2015-08-07 B Purchase Hinrichs James F.

Executive VP, CFO

Officer
20,000 +inf%
49.33
US$986,570 		20,000 +inf% 49.33 US$986,570
2015-06-10 2015-06-08 S Sale Malkani Sanjay

Global Pres., Toxicology

Officer
24,331 -79.6%
50.87
US$1,237,645 		24,331 -79.6% 50.87 US$1,237,645
2015-06-08 2015-06-04 S Sale Malkani Sanjay

Global Pres., Toxicology

Officer
15,669 -71.6%
52.18
US$817,640 		15,669 -71.6% 52.18 US$817,640
2015-06-02 2015-06-01 S Sale BRIDGEN JOHN

Sr VP, Business Develop

Officer
7,500 -62.2%
51.19
US$383,932 		7,500 -62.2% 51.19 US$383,932
2015-06-02 2015-05-29 S Sale BRIDGEN JOHN

Sr VP, Business Develop

Officer
22,564 -83.2%
51.17
US$1,154,487 		22,564 -83.2% 51.17 US$1,154,487
2015-05-04 2015-04-30 PlS Planned sale Guerdan Melissa

SVP, Global Quality & Reg.

Officer
3,031 -100.0%
47.81
US$144,912 		3,031 -100.0% 47.81 US$144,912
2015-04-08 2015-04-06 PlS Planned sale Guerdan Melissa

SVP, Global Quality & Reg.

Officer
2,500 -100.0%
50.00
US$125,000 		2,500 -100.0% 50.00 US$125,000
2015-03-25 2015-03-23 PlS Planned sale Guerdan Melissa

SVP, Global Quality & Reg.

Officer
13,476 -100.0%
48.35
US$651,497 		13,476 -100.0% 48.35 US$651,497
2015-03-19 2015-03-17 S Sale BRIDGEN JOHN

Sr VP, Business Develop

Officer
25,000 -84.6%
48.53
US$1,213,250 		25,000 -84.6% 48.53 US$1,213,250
2015-03-18 2015-03-16 S Sale Flakne Carla

VP, Chief Accounting Officer

Officer
8,500 -100.0%
48.99
US$416,449 		8,500 -100.0% 48.99 US$416,449
2015-02-25 2015-02-23 S Sale Gladwell Mark

Senior VP, Global Operations

Officer
792 -100.0%
44.66
US$35,374 		792 -100.0% 44.66 US$35,374
2015-02-25 2015-02-23 S Sale Gladwell Mark

Senior VP, Global Operations

Officer
12,500 -94.0%
44.61
US$557,662 		12,500 -94.0% 44.61 US$557,662
2015-01-20 2015-01-16 PlS Planned sale Flakne Carla

VP, Chief Accounting Officer

Officer
10,000 -75.5%
42.45
US$424,450 		10,000 -75.5% 42.45 US$424,450
2015-05-15 2015-01-13 S Sale GOLDBERG CAROL R Non-Executive Director
110 -100.0%
39.46
US$4,341 		110 -100.0% 39.46 US$4,341
2014-12-12 2014-12-11 S Sale BRIDGEN JOHN

Sr VP, Business Develop

Officer
50,000 -91.7%
37.07
US$1,853,400 		50,000 -91.7% 37.07 US$1,853,400
2014-08-18 2014-08-15 PlS Planned sale Teitel Dave

Chief Financial Officer

Officer
10,000 -66.7%
35.07
US$350,700 		10,000 -66.7% 35.07 US$350,700
2013-12-13 2013-12-11 S Sale Torchilin Kate

VP, Connected Health

Officer
575 -21.3%
33.73
US$19,393 		575 -21.3% 33.73 US$19,393
2013-12-13 2013-12-11 S Sale Torchilin Kate

VP, Connected Health

Officer
7,972 -79.7%
33.73
US$268,872 		7,972 -79.7% 33.73 US$268,872
2013-11-14 2013-11-13 S Sale HEMPEL PAUL T

SVP Ethics & Compliance

Officer
921 -4.4%
33.68
US$31,016 		921 -4.4% 33.68 US$31,016
2013-11-14 2013-11-12 S Sale HEMPEL PAUL T

SVP Ethics & Compliance

Officer
3,655 -15.5%
33.75
US$123,356 		3,655 -15.5% 33.75 US$123,356
2013-08-16 2013-08-15 PlS Planned sale Teitel Dave

Chief Financial Officer

Officer
10,000 -68.9%
31.73
US$317,282 		10,000 -68.9% 31.73 US$317,282
2013-08-07 2013-08-05 S Sale Cotton Michael Lester

Global Pres, Health Mgmt

Officer
12,500 -100.0%
33.82
US$422,750 		12,500 -100.0% 33.82 US$422,750
2013-06-04 2013-05-31 S Sale Cotton Michael Lester

Global Pres, Health Mgmt

Officer
8,750 -100.0%
25.86
US$226,240 		8,750 -100.0% 25.86 US$226,240
2013-03-11 2013-03-07 S Sale Post Jim

President, Acute Care

Officer
1,075 -100.0%
23.37
US$25,123 		1,075 -100.0% 23.37 US$25,123
2013-03-07 2013-03-05 S Sale QUELCH JOHN Non-Executive Director
20,220 -67.4%
23.49
US$475,065 		20,220 -67.4% 23.49 US$475,065
2013-03-05 2013-03-01 PlS Planned sale EYLENBOSCH HILDE

President, Alere International

Officer
2,391 -7.3%
22.69
US$54,245 		2,391 -7.3% 22.69 US$54,245
2012-08-16 2012-08-14 S Sale TOOHEY DAVID

President, Intl Bus. Operation

Officer
151 -1.6%
18.28
US$2,760 		151 -1.6% 18.28 US$2,760
2012-08-09 2012-08-07 PlS Planned sale BRIDGEN JOHN

Sr VP, Business Develop

Officer
11,721 -81.7%
18.96
US$222,218 		11,721 -81.7% 18.96 US$222,218
2012-07-23 2012-07-19 PlS Planned sale BRIDGEN JOHN

VP, Strategic Business Develop

Officer
4,752 -64.3%
20.00
US$95,040 		4,752 -64.3% 20.00 US$95,040
2012-06-15 2012-06-13 S Sale HEMPEL PAUL T

SVP Ethics & Compliance

Officer
1,700 -8.4%
19.03
US$32,352 		1,700 -8.4% 19.03 US$32,352
2012-06-15 2012-06-13 S Sale HEMPEL PAUL T

SVP Ethics & Compliance

Officer
8,213 -28.9%
19.00
US$156,047 		8,213 -28.9% 19.00 US$156,047
2012-06-15 2012-06-13 S Sale HEMPEL PAUL T

SVP Ethics & Compliance

Officer
200 -0.7%
19.01
US$3,802 		200 -0.7% 19.01 US$3,802
2012-03-09 2012-03-07 PlS Planned sale BRIDGEN JOHN

VP, Strategic Business Develop

Officer
4,357 -62.3%
25.00
US$108,925 		4,357 -62.3% 25.00 US$108,925
2012-02-21 2012-02-16 S Sale Underwood Thomas

CEO, Alere Health LLC

Officer
750 -33.3%
26.02
US$19,516 		750 -33.3% 26.02 US$19,516
2012-02-09 2012-02-07 PlS Planned sale BRIDGEN JOHN

VP, Strategic Business Develop

Officer
5,446 -67.4%
25.10
US$136,695 		5,446 -67.4% 25.10 US$136,695
2012-02-06 2012-02-02 PlS Planned sale BRIDGEN JOHN

VP, Strategic Business Develop

Officer
6,808 -72.1%
25.00
US$170,200 		6,808 -72.1% 25.00 US$170,200
2011-11-30 2011-11-28 PlS Planned sale MCALEER JEROME F

VP, Research & Development

Executive Director
116,829 -28.2%
22.25
US$2,599,212 		116,829 -28.2% 22.25 US$2,599,212
2011-11-17 2011-11-15 PlS Planned sale EYLENBOSCH HILDE

Chief Commercial Officer

Officer
17,229 -36.4%
26.02
US$448,367 		17,229 -36.4% 26.02 US$448,367
2011-08-24 2011-08-23 B Purchase Roosevelt James Jr. Non-Executive Director
4,444 +inf%
22.50
US$99,990 		4,444 +inf% 22.50 US$99,990
2011-08-12 2011-08-11 B Purchase Underwood Thomas

CEO, Alere Health LLC

Officer
1,500 +inf%
23.44
US$35,160 		1,500 +inf% 23.44 US$35,160
2011-08-10 2011-08-09 B Purchase Hargadon Robert Bernard

VP, Global Culture & Performan

Officer
600 +25.0%
22.90
US$13,740 		600 +25.0% 22.90 US$13,740
2011-08-10 2011-08-09 B Purchase Hargadon Robert Bernard

VP, Global Culture & Performan

Officer
1,400 +140.0%
22.93
US$32,101 		1,400 +140.0% 22.93 US$32,101
2011-03-17 2011-03-15 S Sale HEMPEL PAUL T

SVP Ethics & Compliance

Officer
13,034 -43.3%
36.75
US$479,000 		13,034 -43.3% 36.75 US$479,000
2011-03-17 2011-03-15 S Sale HEMPEL PAUL T

SVP Ethics & Compliance

Officer
6,175 -17.0%
36.76
US$226,968 		6,175 -17.0% 36.76 US$226,968
2010-11-16 2010-11-12 S Sale HEMPEL PAUL T

Sr VP, LD & Legal Affairs

Officer
1,020 -9.3%
29.22
US$29,804 		1,020 -9.3% 29.22 US$29,804
2010-08-31 2010-08-27 B Purchase Adashi Eli Non-Executive Director
850 +inf%
28.80
US$24,480 		850 +inf% 28.80 US$24,480
2010-08-03 2010-07-30 B Purchase QUELCH JOHN Non-Executive Director
4,600 +1150.0%
28.36
US$130,439 		4,600 +1150.0% 28.36 US$130,439
2010-08-03 2010-07-30 B Purchase QUELCH JOHN Non-Executive Director
400 +inf%
28.24
US$11,296 		400 +inf% 28.24 US$11,296
2010-05-19 2010-05-17 S Sale HEMPEL PAUL T

Sr VP, LD & Legal Affairs

Officer
300 -3.3%
37.02
US$11,106 		300 -3.3% 37.02 US$11,106
2010-05-19 2010-05-17 S Sale HEMPEL PAUL T

Sr VP, LD & Legal Affairs

Officer
745 -7.6%
37.04
US$27,595 		745 -7.6% 37.04 US$27,595
2010-05-19 2010-05-17 S Sale HEMPEL PAUL T

Sr VP, LD & Legal Affairs

Officer
100 -1.0%
37.05
US$3,705 		100 -1.0% 37.05 US$3,705
2012-04-30 2010-04-26 PlS Planned sale BRIDGEN JOHN

VP, Strategic Business Develop

Officer
3,486 -57.0%
25.00
US$87,150 		3,486 -57.0% 25.00 US$87,150
2010-02-23 2010-02-19 S Sale TOWNSEND PETER Non-Executive Director
8,333 -100.0%
39.40
US$328,320 		8,333 -100.0% 39.40 US$328,320
2009-06-18 2009-06-16 S Sale KHEDERIAN ROBERT P Non-Executive Director
25,000 -55.6%
32.74
US$818,585 		25,000 -55.6% 32.74 US$818,585
2009-06-18 2009-06-16 S Sale SCOTT DAVID

Chief Technical Officer

Executive Director
22,700 -5.0%
32.24
US$731,959 		22,700 -5.0% 32.24 US$731,959
2009-03-02 2009-02-26 S Sale KHEDERIAN ROBERT P Non-Executive Director
25,000 -55.6%
23.93
US$598,150 		25,000 -55.6% 23.93 US$598,150
2008-12-03 2008-12-01 S Sale KHEDERIAN ROBERT P Non-Executive Director
5,000 -20.0%
17.02
US$85,120 		5,000 -20.0% 17.02 US$85,120
2008-11-24 2008-11-24 B Purchase ZWANZIGER RON

Chairman, CEO & President

Executive Director
1,500 +0.8%
16.08
US$24,120 		1,500 +0.8% 16.08 US$24,120
2008-11-24 2008-11-24 B Purchase ZWANZIGER RON

Chairman, CEO & President

Executive Director
55,500 +41.2%
15.56
US$863,580 		55,500 +41.2% 15.56 US$863,580
2008-11-24 2008-11-24 B Purchase ZWANZIGER RON

Chairman, CEO & President

Executive Director
7,000 +5.5%
14.92
US$104,440 		7,000 +5.5% 14.92 US$104,440
2008-11-25 2008-11-21 B Purchase MCALEER JEROME F

VP, Research & Development

Executive Director
55,555 +27.6%
13.43
US$746,193 		55,555 +27.6% 13.43 US$746,193
2008-11-24 2008-11-21 S Sale KHEDERIAN ROBERT P Non-Executive Director
4,600 -15.5%
13.56
US$62,376 		4,600 -15.5% 13.56 US$62,376
2008-11-24 2008-11-21 S Sale KHEDERIAN ROBERT P Non-Executive Director
15,400 -34.2%
14.73
US$226,842 		15,400 -34.2% 14.73 US$226,842
2008-11-24 2008-11-20 S Sale KHEDERIAN ROBERT P Non-Executive Director
53,190 -54.2%
14.73
US$783,489 		53,190 -54.2% 14.73 US$783,489
2008-11-24 2008-11-20 S Sale KHEDERIAN ROBERT P Non-Executive Director
26,810 -21.4%
13.92
US$373,195 		26,810 -21.4% 13.92 US$373,195
2008-06-05 2008-06-05 B Purchase KHEDERIAN ROBERT P Non-Executive Director
5,000 +4.2%
38.56
US$192,800 		5,000 +4.2% 38.56 US$192,800
2008-06-03 2008-06-02 B Purchase ZWANZIGER RON

Chairman, CEO & President

Executive Director
27,600 +27.5%
36.16
US$998,016 		27,600 +27.5% 36.16 US$998,016
2008-03-05 2008-03-05 B Purchase JENKINS GEOFFREY

VP, Worldwide Operations

Officer
833 +inf%
30.25
US$25,198 		833 +inf% 30.25 US$25,198
Explore more

More insider trading research around Alere Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America